Summary of Components of Preliminary Purchase Price Allocation for Acquisition of Vilebrequin (Detail) (Vilebrequin)	Aug. 07, 2012 USD ($)	Aug. 07, 2012 EUR (€)
Purchase price:
Cash paid	$ 87,573,000	€ 70,500,000
Notes issued	18,633,000	15,000,000
Fair value of contingent consideration	5,452,000
Total consideration paid by the Company in business acquisition	111,658,000
Allocation:
Current assets	25,793,000
Property, plant and equipment	5,724,000
Identifiable intangible assets	68,847,000
Other non-current assets, net	4,551,000
Assumed liabilities	(12,938,000)
Deferred income taxes	(12,515,000)
Goodwill	32,196,000
Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net, Total	$ 111,658,000